Latest news with #SurakshaDiagnostic
Business Standard
7 days ago
- Business
- Business Standard
Suraksha Diagnostic consolidated net profit rises 13.34% in the March 2025 quarter
Sales rise 17.94% to Rs 65.09 crore Net profit of Suraksha Diagnostic rose 13.34% to Rs 7.39 crore in the quarter ended March 2025 as against Rs 6.52 crore during the previous quarter ended March 2024. Sales rose 17.94% to Rs 65.09 crore in the quarter ended March 2025 as against Rs 55.19 crore during the previous quarter ended March 2024. For the full year,net profit rose 34.66% to Rs 31.82 crore in the year ended March 2025 as against Rs 23.63 crore during the previous year ended March 2024. Sales rose 15.26% to Rs 252.09 crore in the year ended March 2025 as against Rs 218.71 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 65.0955.19 18 252.09218.71 15 OPM % 29.4735.28 - 32.2332.04 - PBDT 17.9418.37 -2 76.7064.83 18 PBT 9.2110.01 -8 41.4132.23 28 NP 7.396.52 13 31.8223.63 35
Business Standard
7 days ago
- Business
- Business Standard
Suraksha Diagnostic standalone net profit rises 17.11% in the March 2025 quarter
Sales rise 15.86% to Rs 64.15 crore Net profit of Suraksha Diagnostic rose 17.11% to Rs 8.01 crore in the quarter ended March 2025 as against Rs 6.84 crore during the previous quarter ended March 2024. Sales rose 15.86% to Rs 64.15 crore in the quarter ended March 2025 as against Rs 55.37 crore during the previous quarter ended March 2024. For the full year,net profit rose 37.16% to Rs 33.44 crore in the year ended March 2025 as against Rs 24.38 crore during the previous year ended March 2024. Sales rose 13.99% to Rs 249.10 crore in the year ended March 2025 as against Rs 218.52 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 64.1555.37 16 249.10218.52 14 OPM % 30.9035.99 - 33.1632.58 - PBDT 18.7018.86 -1 78.5966.05 19 PBT 10.0410.53 -5 43.8633.48 31 NP 8.016.84 17 33.4424.38 37
Economic Times
27-05-2025
- Business
- Economic Times
PG Electroplast block deal: Government of Singapore buys shares worth Rs 288 crore in multibagger smallcap
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel The Government of Singapore bought shares worth Rs 288 crore in PG Electroplast via a block deal on Tuesday. It bought over 38.18 lakh shares at a price of Rs 754.80 per share which is a 2% discount over the Monday closing price of Rs another block deal, BNP Paribas Financial Markets bought nearly 3 lakh shares worth Rs 10 crore in smallcap counter Suraksha Diagnostic . The asset management arm of French multinational bank BNP Paribas purchased shares at a price of Rs 338 per share, up by 0.9% over the previous losing Electroplast is a diversified EMS player in India and offers comprehensive ODM and OEM solutions to 60+ Indian and global brands across the consumer electronics and consumer durables industries. Its product line includes air conditioners, washing machines, LED television and air Electroplast is a smallcap multibagger and has delivered returns of 200% over the past 12 months. However, the stock has been under consolidation and has corrected by 25% in 2025 so recent correction has brought it below its 50-day simple moving average of Rs 867 while it is still trading above its 200-day SMA of Rs 753. The stock has been quite volatile and has traded with a 1-year beta of Electroplast reported a consolidated net profit of Rs 145 crore in Q4FY25 which was up from 70 crore posted by the company in the year ago period, recording a 107% year-on-year growth. Total revenue in the quarter under review stood at Rs 1,930 crore, up 79% over Rs 1,080 crore reported in the corresponding quarter of the last financial Read: Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal Meanwhile, December listed Suraksha Diagnostic is a Kolkata-based pathology and radiology services company which has presence in eastern and north-eastern India. The stock has fallen 21% since its listing while plunging 14% on a year-to-date basis. The stock is currently trading above its 50-day SMA.
Time of India
27-05-2025
- Business
- Time of India
PG Electroplast block deal: Government of Singapore buys shares worth Rs 288 crore in multibagger smallcap
The Government of Singapore bought shares worth Rs 288 crore in PG Electroplast via a block deal on Tuesday. It bought over 38.18 lakh shares at a price of Rs 754.80 per share which is a 2% discount over the Monday closing price of Rs 771.55. In another block deal, BNP Paribas Financial Markets bought nearly 3 lakh shares worth Rs 10 crore in smallcap counter Suraksha Diagnostic . The asset management arm of French multinational bank BNP Paribas purchased shares at a price of Rs 338 per share, up by 0.9% over the previous losing price. PG Electroplast is a diversified EMS player in India and offers comprehensive ODM and OEM solutions to 60+ Indian and global brands across the consumer electronics and consumer durables industries. Its product line includes air conditioners, washing machines, LED television and air coolers. PG Electroplast is a smallcap multibagger and has delivered returns of 200% over the past 12 months. However, the stock has been under consolidation and has corrected by 25% in 2025 so far. The recent correction has brought it below its 50-day simple moving average of Rs 867 while it is still trading above its 200-day SMA of Rs 753. The stock has been quite volatile and has traded with a 1-year beta of 1.8. Live Events PG Electroplast reported a consolidated net profit of Rs 145 crore in Q4FY25 which was up from 70 crore posted by the company in the year ago period, recording a 107% year-on-year growth. Total revenue in the quarter under review stood at Rs 1,930 crore, up 79% over Rs 1,080 crore reported in the corresponding quarter of the last financial year. Also Read: Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal Meanwhile, December listed Suraksha Diagnostic is a Kolkata-based pathology and radiology services company which has presence in eastern and north-eastern India. The stock has fallen 21% since its listing while plunging 14% on a year-to-date basis. The stock is currently trading above its 50-day SMA.
